Primary study · included by 1 review

Cho 2022

Included by

Prognostic Significance of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Tumor-Associated Neutrophils in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.

Non-Cochrane · prognostic · 2026 · cited as Cho 2022 · Table S3; reference 34

The review does not say which of its outcomes this study informs.

1 including review in total.